H04.14 Primary lacrimal gland atrophy

Name of the Condition

• Primary Lacrimal Gland Atrophy (ICD-10 code: H04.14)

Summary

Primary lacrimal gland atrophy is a condition characterized by the progressive degeneration or shrinkage of the lacrimal gland, which is responsible for tear production. This can lead to reduced tear output, resulting in dry eye symptoms or other ocular discomfort. The condition is classified as "primary" when it occurs without an identifiable underlying cause, distinguishing it from secondary atrophy linked to other diseases or trauma.

Causes

The exact cause of primary lacrimal gland atrophy is not fully understood. It is thought to involve age-related changes, autoimmune processes, or degenerative mechanisms affecting the gland tissue. Unlike secondary atrophy, no specific infection, trauma, or systemic disease is identified as the trigger in primary cases.

Risk Factors

Risk factors may include advanced age, as glandular tissue naturally declines over time. Genetic predisposition or a history of autoimmune conditions could also increase susceptibility, though specific associations are not well established for primary cases.

Symptoms

Symptoms typically include persistent dryness, burning, or grittiness in the eyes. Patients may experience reduced tear production, leading to discomfort, redness, or a sensation of foreign bodies. Vision may be temporarily blurred, especially in dry environments, and eye fatigue is common.

Diagnosis

Diagnosis involves a clinical evaluation, including a review of symptoms and tear production assessment (e.g., Schirmer test). Imaging studies like MRI or CT scans may be used to visualize gland size and rule out other conditions. Biopsy is rarely needed but can confirm atrophy if uncertainty exists.

Treatment Options

Treatment focuses on managing symptoms, such as using artificial tears or lubricating eye drops to alleviate dryness. In some cases, anti-inflammatory medications or punctal plugs may be recommended to retain natural tears. Underlying causes are not addressed, as the condition is primary.

Prognosis and Follow-Up

Prognosis is generally stable, with symptoms managed rather than reversed. Regular follow-up with an eye care provider is advised to monitor tear production and adjust treatments as needed. Severe cases may require ongoing symptom management.

Complications

Complications can include chronic eye irritation, increased risk of corneal damage from dryness, or reduced quality of life due to persistent discomfort. In rare instances, secondary infections may occur if the eye surface is compromised.

Lifestyle & Prevention

Lifestyle measures include using humidifiers to reduce environmental dryness, avoiding prolonged screen time, and protecting eyes from wind or smoke. Omega-3 supplements may help support tear film stability, though evidence is limited for primary atrophy.

When to Seek Professional Help

Seek care if dry eye symptoms worsen, vision changes occur, or eye pain develops. Persistent redness, discharge, or sensitivity to light should also prompt evaluation to rule out other conditions.

Tips for Medical Coders

Document the diagnosis as "primary lacrimal gland atrophy" (H04.14) when no secondary cause is identified. Ensure clinical notes specify the absence of trauma, infection, or systemic disease to support the primary classification. Coding should reflect the degenerative nature of the condition without implying a specific etiology.